Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 |  STARTUP | Patent: 17 | ||
2 |  STARTUP | Diabetes Therapy,Health care | Patent: 4 | |
3 |  STARTUP | Patent: 1 | ||
4 |  STARTUP | Patent: 1 | ||
5 |  STARTUP | Patent: 1 |
Top 5 Startups & Unicorns companies in Hyperlipidemia
by Most Patent Filings in the United States in 2022
The Hyperlipidemia top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filings Hyperlipidemia Startups & Unicorns in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.
Page generation time:
May 21 2025